Guardant Health
GH
#1787
Rank
โ‚น1.046 T
Marketcap
โ‚น7,980
Share price
-3.96%
Change (1 day)
106.24%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -โ‚น36.59 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚น0.98 Billion. , an increase over its 2024 earnings that were of -โ‚น41.04 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น39.38 Billion-4.03%
2024 -โ‚น41.04 Billion-9.12%
2023 -โ‚น45.16 Billion-26.73%
2022 -โ‚น61.63 Billion69.96%
2021 -โ‚น36.26 Billion56.35%
2020 -โ‚น23.2 Billion252.69%
2019 -โ‚น6.58 Billion-17.22%
2018 -โ‚น7.95 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-โ‚น58.24 Billion 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น25.29 Billion-35.79%๐Ÿ‡บ๐Ÿ‡ธ USA